Research Analysts Issue Forecasts for ACHC FY2024 Earnings

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Stock analysts at Zacks Research lifted their FY2024 earnings per share (EPS) estimates for shares of Acadia Healthcare in a research note issued on Wednesday, December 18th. Zacks Research analyst Z. Masood now expects that the company will post earnings per share of $3.39 for the year, up from their previous forecast of $3.37. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share. Zacks Research also issued estimates for Acadia Healthcare’s Q4 2024 earnings at $0.73 EPS, Q1 2025 earnings at $0.77 EPS and Q4 2025 earnings at $0.99 EPS.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. The company had revenue of $815.60 million for the quarter, compared to the consensus estimate of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm’s revenue was up 8.7% compared to the same quarter last year. During the same period last year, the company earned $0.91 earnings per share.

Several other research firms have also issued reports on ACHC. Cantor Fitzgerald restated a “neutral” rating and issued a $52.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, December 10th. Barclays cut their price target on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a report on Friday, November 22nd. Royal Bank of Canada reduced their price objective on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a report on Monday, November 18th. StockNews.com upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Thursday. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $45.00 to $75.00 in a research note on Thursday, December 12th. Four investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $75.44.

Acadia Healthcare Stock Down 1.8 %

Acadia Healthcare stock opened at $37.90 on Monday. Acadia Healthcare has a fifty-two week low of $36.50 and a fifty-two week high of $87.77. The firm has a market capitalization of $3.52 billion, a PE ratio of 12.43, a P/E/G ratio of 1.77 and a beta of 1.29. The company’s 50-day moving average is $43.80 and its 200-day moving average is $60.81. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Wellington Management Group LLP raised its stake in shares of Acadia Healthcare by 12.2% in the third quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock worth $739,250,000 after purchasing an additional 1,266,384 shares during the last quarter. William Blair Investment Management LLC lifted its position in shares of Acadia Healthcare by 20.7% during the second quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock valued at $237,434,000 after purchasing an additional 604,070 shares in the last quarter. State Street Corp boosted its holdings in Acadia Healthcare by 3.5% during the third quarter. State Street Corp now owns 2,819,911 shares of the company’s stock worth $178,811,000 after purchasing an additional 95,613 shares during the last quarter. Point72 Asset Management L.P. grew its position in Acadia Healthcare by 0.5% in the 3rd quarter. Point72 Asset Management L.P. now owns 2,282,810 shares of the company’s stock worth $144,753,000 after purchasing an additional 12,470 shares in the last quarter. Finally, Geode Capital Management LLC increased its stake in Acadia Healthcare by 0.9% in the 3rd quarter. Geode Capital Management LLC now owns 1,613,198 shares of the company’s stock valued at $102,320,000 after buying an additional 14,197 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.